437 related articles for article (PubMed ID: 6255005)
1. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
2. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
[TBL] [Abstract][Full Text] [Related]
3. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
Lawoyin S; Zerwekh JE; Glass K; Pak CY
J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
[TBL] [Abstract][Full Text] [Related]
4. Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups.
Zerwekh JE; Sakhaee K; Glass K; Pak CY
J Clin Endocrinol Metab; 1983 Feb; 56(2):410-3. PubMed ID: 6600460
[TBL] [Abstract][Full Text] [Related]
5. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
6. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Cosman F; Nieves J; Shen V; Lindsay R
J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
[TBL] [Abstract][Full Text] [Related]
7. A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D.
Riggs BL; Gallagher JC; DeLuca HF; Edis AJ; Lambert PW; Arnaud CD
Mayo Clin Proc; 1978 Nov; 53(11):701-6. PubMed ID: 713601
[TBL] [Abstract][Full Text] [Related]
8. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption.
Chipman JJ; Zerwekh J; Nicar M; Marks J; Pak CY
J Clin Endocrinol Metab; 1980 Aug; 51(2):321-4. PubMed ID: 6249837
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between serum 1,25-dihydroxyvitamin D and bone loss in postmenopausal women].
Zhu G; Wang H; Xu P
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1443-6. PubMed ID: 11930618
[TBL] [Abstract][Full Text] [Related]
10. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
[TBL] [Abstract][Full Text] [Related]
11. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
12. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
[TBL] [Abstract][Full Text] [Related]
13. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
Aksnes L; Aarskog D
J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolism in hypoparathyroidism.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
[TBL] [Abstract][Full Text] [Related]
16. Assessment of 25-hydroxyvitamin D 1 alpha-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract.
Riggs BL; Hamstra A; DeLuca HF
J Clin Endocrinol Metab; 1981 Oct; 53(4):833-5. PubMed ID: 7287865
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
[TBL] [Abstract][Full Text] [Related]
18. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
19. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
Kinyamu HK; Gallagher JC; Petranick KM; Ryschon KL
J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
